Oculus Innovative Sciences is a biopharmaceutical company that develops, manufactures and markets a wide spectrum of products based upon the shelf-stable Microcyn^® Technology platform, which is intended to help prevent and treat infections in wounds, burns and diseases. Microcyn has demonstrated the ability to safety treat a wide range of pathogens, including antibiotic-resistant strains of bacteria such as MRSA, viruses, fungi and spores.